HSBC Holdings’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-39,452
Closed -$526K 2741
2025
Q1
$526K Buy
+39,452
New +$526K ﹤0.01% 1629